This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63814494
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування ensayu clínicu կլինիկական փորձարկում klinisch onderzoek
rdfs:label
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
skos:prefLabel
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
schema:name
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
p:P1476
wds:Q63814494-9DD5D040-7AD3-42B8-B53F-3E4DEF2D3124
wdt:P1476
A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib (NSC # 681239) and Bendamustine in Patients With Untreated Follicular Lymphoma
p:P582
wds:Q63814494-36F78093-59DD-4906-9C20-B49C23C88D16
wdt:P582
2017-05-24T00:00:00Z
p:P31
wds:Q63814494-062C991E-0D3F-4A4D-8A02-C11A60FFC409
wdt:P31
wd:Q30612
p:P580
wds:Q63814494-0CC1F9D4-03D6-43BC-B25D-38AFBDE92DFB
wdt:P580
2011-04-08T00:00:00Z
p:P6153
wds:Q63814494-1319C11F-9894-4810-9D10-DA42F919A9B7 wds:Q63814494-152215D8-2544-40C4-8E6F-DAB9149ED6E4 wds:Q63814494-CAC9D85A-AA29-4643-9769-7B23D0178D42 wds:Q63814494-EF81B5A3-DBC7-43A2-ABA7-0E80AC2E8F4F wds:Q63814494-F396CD94-4732-45A5-8AED-15CF315AB00B wds:Q63814494-1D411B34-67F6-475B-AF36-301A6020B31F wds:Q63814494-25CE23A3-D16E-44DD-8600-6999E6406E68 wds:Q63814494-38C6C89C-777E-45E8-A5B9-A1F3514E4B25 wds:Q63814494-3F0DD2DE-F1E2-4A6B-A9F8-9E5806098692 wds:Q63814494-4482BC98-83DA-4EA5-8934-EDEB415AE3D2 wds:Q63814494-4C15845D-581B-4C73-98AE-5C9785491E59 wds:Q63814494-54F51338-DAF2-4A38-9D53-6A68A094EB86 wds:Q63814494-59AB2321-2318-4B2C-93B4-7EAAA5F53BEF wds:Q63814494-5A513A52-C010-47A2-A9C3-06A5792A287B wds:Q63814494-B2E8722E-E8B4-4E82-8088-F0D38D99F9D6 wds:Q63814494-B3B2BB9B-ABAB-4D5A-B182-26E8F279E0DE wds:Q63814494-B411333D-BE82-40F4-BD53-F135F6FB1944
wdt:P6153
wd:Q6672700 wd:Q519349 wd:Q457281 wd:Q7972509 wd:Q61673301 wd:Q5330270 wd:Q7401747 wd:Q115376 wd:Q192334 wd:Q7896014 wd:Q309331 wd:Q131252 wd:Q22033932 wd:Q6815474 wd:Q392667 wd:Q6031854 wd:Q622664
p:P4844
wds:Q63814494-D4AE5140-5A1D-4C40-95FD-0883F95F39D9
wdt:P4844
wd:Q27272066
p:P2899
wds:Q63814494-973BA5BC-F172-4514-B8D8-43FE822E65BA
wdt:P2899
18
p:P1050
wds:Q63814494-1B264A53-16AE-431D-8268-9A1B08C70261
wdt:P1050
wd:Q208414
p:P1132
wds:Q63814494-52C379F5-6F83-4B1F-A1EF-C80A75A87DD0
wdt:P1132
135
p:P8363
wds:Q63814494-E3EF0771-BBA5-4A5D-B634-02809587A0A3
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63814494-F0BDF212-8318-4458-AFEC-E4805F53FF12
wdt:P3098
NCT01286272
p:P6099
wds:Q63814494-0CD441E8-0279-4921-86D8-8DDF53092FC3
wdt:P6099
wd:Q42824440